The goal of Structural Biology (SB) Core (formerly X-Ray Crystallography Core) is to provide access to expertise as well as state-of-the-art equipment and software to Center laboratories that address structural questions within their research. Understanding the biological processes involved in tumorigenesis has increasingly benefitted from structural investigations that provide key functional and mechanistic insights, as well as atomic-level details important for drug discovery. Many of the questions require the structure determination of large proteins, assemblies and macromolecular machines. The Core maintains in house equipment (Rigaku Micromax 007hf diffractometer and Titan Krios-Gatan K2 cryo electron microscope) and computational resources for data collection, processing and structure determination, including graphical workstations and a high-performance Linux cluster. The SB Core implements a range of software packages for structural determination and analysis, participates in multi-institutional consortia for access to synchrotron beamlines and cryoEM and provides training and assistance to users. In addition, the Core Head collaborates with non-structural MSK groups on macromolecular crystallization and structure-determination projects, and also provides modeling expertise and guidance to those labs that can benefit from the use of available structures in the design and interpretation of experiments. The SB Core has supported 9 investigators in the past year and has contributed to 127 publications of investigators from 3 programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA008748-53
Application #
9631231
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
53
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Fanale, Michelle A; Horwitz, Steven M; Forero-Torres, Andres et al. (2018) Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas. Blood 131:2120-2124
Barzilai, Ori; DiStefano, Natalie; Lis, Eric et al. (2018) Safety and utility of kyphoplasty prior to spine stereotactic radiosurgery for metastatic tumors: a clinical and dosimetric analysis. J Neurosurg Spine 28:72-78
Rosenberg, Jonathan B; Kaplitt, Michael G; De, Bishnu P et al. (2018) AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease. Hum Gene Ther Clin Dev 29:24-47
Ma, Jennifer; Lok, Benjamin H; Zong, Jingfeng et al. (2018) Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot. Int J Part Ther 4:10-19
Hieronymus, Haley; Murali, Rajmohan; Tin, Amy et al. (2018) Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death. Elife 7:
Garg, Angad; Goldgur, Yehuda; Schwer, Beate et al. (2018) Distinctive structural basis for DNA recognition by the fission yeast Zn2Cys6 transcription factor Pho7 and its role in phosphate homeostasis. Nucleic Acids Res 46:11262-11273
Scordo, Michael; Shah, Gunjan L; Kosuri, Satyajit et al. (2018) Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 24:133-141
Wei, Iris H; Garcia-Aguilar, Julio (2018) Non-operative management of rectal cancer: understanding tumor biology. Minerva Chir 73:601-618
Murali, Rajmohan; Grisham, Rachel N; Soslow, Robert A (2018) The roles of pathology in targeted therapy of women with gynecologic cancers. Gynecol Oncol 148:213-221
Gounder, Mrinal M; Mahoney, Michelle R; Van Tine, Brian A et al. (2018) Sorafenib for Advanced and Refractory Desmoid Tumors. N Engl J Med 379:2417-2428

Showing the most recent 10 out of 8799 publications